Chris Erickson
General Partner @ Pangaea Ventures
Phoenix, United States
Chris Erickson is a Series A investor at Pangaea Ventures in Phoenix focused on Manufacturing and Chemical. Chris Erickson is based out of Phoenix, Arizona. and is the Partner of Pangaea Ventures. Chris previously worked at Redlen Technologies as Former Director. Chris Erickson attended the University of Toronto.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 86%
Last updated:
For AI agents: llms.txt
Industries Chris Erickson invests in
Stages Chris Erickson invests in
Countries Chris Erickson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Manufacturing 3 (43%)
- Chemical 2 (29%)
- Medical 1 (14%)
- Textiles 1 (14%)
- Nutrition 1 (14%)
Stage
- Series A 3 (43%)
- Series B 2 (29%)
- Series C 1 (14%)
- Funding Round 1 (14%)
Country
- United States 3 (43%)
- Canada 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Green Theme Technologies
|
Green Theme Technologies is a developer of environmentally-friendly, dry textile finishing technology. It is a textile innovation company with the mission to create products that out-perform existing technologies while eliminating water usage and pollution. The company was founded in 2012 and is based in Rio Rancho, New Mexico. | $6M / Series C / Nov 06, 2024 | |
Ardent Process Technologies
|
Compact Membrane Systems specializes in providing scalable membrane solutions for the decarbonization revolution. It develops technology to capture and reduce greenhouse gas emissions, avert global warming, and transform the industry into a long-term sustainable enterprise. | $16.5M / Series A / Aug 02, 2023 | |
Flore by Sun Genomics
|
Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completelypersonalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes. | $9.3M / Series A / Jun 29, 2020 | |
Redlen Technologies
|
Redlen Technologies is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are enabling a new generation of high performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection.Having successfully pioneered a breakthroughproduction process for manufacturing advanced CZT semiconductor wafers with its proprietary Traveling Heater Method (THM) technology, Redlen is revolutionizing the performance, cost and availability of radiation detection and imaging – enabling the widespread adoption of this technology for the medical and security markets.The company also offers an advanced thin film solar Cadmium Telluride (CdTe) feedstock product, delivering volume quantities of high purity, high performance semiconductor material to the Thin Film Solar Photovoltaic (PV) market.With its industry-leading CZT growth technology, pioneered by a management and technical team that is deeply rooted in semiconductor and imaging technology, Redlen is changing the landscape for high performance, cost effective radiation-based medical and security imaging equipment. | Series B / Mar 15, 2017 | |
|
Redlen Technologies
|
Redlen Technologies is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are enabling a new generation of high performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection.Having successfully pioneered a breakthroughproduction process for manufacturing advanced CZT semiconductor wafers with its proprietary Traveling Heater Method (THM) technology, Redlen is revolutionizing the performance, cost and availability of radiation detection and imaging – enabling the widespread adoption of this technology for the medical and security markets.The company also offers an advanced thin film solar Cadmium Telluride (CdTe) feedstock product, delivering volume quantities of high purity, high performance semiconductor material to the Thin Film Solar Photovoltaic (PV) market.With its industry-leading CZT growth technology, pioneered by a management and technical team that is deeply rooted in semiconductor and imaging technology, Redlen is changing the landscape for high performance, cost effective radiation-based medical and security imaging equipment. | Mar 06, 2014 | |
|
Redlen Technologies
|
Redlen Technologies is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are enabling a new generation of high performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection.Having successfully pioneered a breakthroughproduction process for manufacturing advanced CZT semiconductor wafers with its proprietary Traveling Heater Method (THM) technology, Redlen is revolutionizing the performance, cost and availability of radiation detection and imaging – enabling the widespread adoption of this technology for the medical and security markets.The company also offers an advanced thin film solar Cadmium Telluride (CdTe) feedstock product, delivering volume quantities of high purity, high performance semiconductor material to the Thin Film Solar Photovoltaic (PV) market.With its industry-leading CZT growth technology, pioneered by a management and technical team that is deeply rooted in semiconductor and imaging technology, Redlen is changing the landscape for high performance, cost effective radiation-based medical and security imaging equipment. | Series A | |
|
Ardent Process Technologies
|
Compact Membrane Systems specializes in providing scalable membrane solutions for the decarbonization revolution. It develops technology to capture and reduce greenhouse gas emissions, avert global warming, and transform the industry into a long-term sustainable enterprise. | $10.3M / Series B |
Co-Investors
About Pangaea Ventures
Pangaea Ventures invests in companies solving fundamental problems in the world with advanced materials and hard technology; Impact Investor
Pangaea Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Chris Erickson
General Partner
|
|||
Purnesh Seegopaul
General Partner
|
|||
Tracy Hedberg
Director, Finance and Administration
|
|||
Andrew Haughian
General Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chris Erickson invest in?
Chris Erickson invests primarily in Manufacturing, Chemical and Medical startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chris Erickson?
Public channels for Chris Erickson include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Chris Erickson last invest?
The most recent investment recorded for Chris Erickson closed in Nov 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
